论文部分内容阅读
[大食久直:治疗68(1):77,1986(日文)] 目前对胰腺与胆道系统的癌肿通过超声断层和CT检查,已发现许多直径2cm以下的肿瘤,但这种检查昂贵,只能在个别医院进行检查。另外,尿或血液检查做为癌的筛选,多数没有特异性。CA19—9在胰腺癌和胆道系统癌的阳率为50—80％,对预后判定,追踪观察有意义。在良性疾病中CA19—9的阳性率低,为8—13％。本文叙述胰腺癌有特异性的CA19—9糖链抗原和胰腺癌胎儿性抗原(POA)的诊断意义和存在问题。
[Taishi Jakuchi: Treatment 68 (1): 77, 1986 (Japanese)] Currently, cancers of the pancreas and biliary tract are examined by ultrasound and CT. Many tumors with a diameter of 2 cm or less have been found, but such examinations are expensive. Can be checked at individual hospitals. In addition, urine or blood tests are used as screening for cancer, and most are not specific. The positive rate of CA19-9 in pancreatic cancer and biliary system cancer is 50-80%. It is significant for the prognosis and follow-up observation. The positive rate of CA19-9 in benign disease is low, ranging from 8 to 13%. This article describes the diagnostic significance and problems of pancreatic cancer-specific CA19-9 carbohydrate antigen and pancreatic cancer fetal antigen (POA).